Share on StockTwits

Omnicell (NASDAQ:OMCL) VP Nhat H. Ngo sold 1,420 shares of the stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $27.70, for a total transaction of $39,334.00. Following the completion of the transaction, the vice president now directly owns 48,660 shares of the company’s stock, valued at approximately $1,347,882. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Omnicell (NASDAQ:OMCL) traded up 0.15% on Thursday, hitting $27.56. The stock had a trading volume of 171,292 shares. Omnicell has a 52 week low of $18.90 and a 52 week high of $30.33. The stock has a 50-day moving average of $26.50 and a 200-day moving average of $26.69. The company has a market cap of $1.009 billion and a P/E ratio of 37.29.

Omnicell (NASDAQ:OMCL) last released its earnings data on Thursday, May 1st. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.02. The company had revenue of $101.80 million for the quarter, compared to the consensus estimate of $97.49 million. During the same quarter in the previous year, the company posted $0.21 earnings per share. The company’s revenue for the quarter was up 16.9% on a year-over-year basis. Analysts expect that Omnicell will post $1.23 EPS for the current fiscal year.

A number of research firms have recently commented on OMCL. Analysts at Topeka Capital Markets initiated coverage on shares of Omnicell in a research note on Thursday, June 12th. They set a “buy” rating and a $30.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Omnicell in a research note on Thursday, May 29th. They now have a $28.00 price target on the stock. Finally, analysts at Stephens initiated coverage on shares of Omnicell in a research note on Tuesday, May 20th. They set an “overweight” rating on the stock. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $30.71.

Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.